Introduction
============

Cytoplasmic lipid droplets are found in virtually all eukaryotic cells, where they provide a dense source of energy. In higher metazoans, many droplets reside in specialized tissues and provide energy for the entire organism ([@bib42]; [@bib26]). The neutral lipids, mainly triacylglycerols (TAGs) and steryl esters (StEs), are surrounded by a single phospholipid leaflet ([@bib61]) in which a unique constellation of proteins resides ([@bib42]; [@bib7]; [@bib9]; [@bib6]). Although many of these proteins catalyze the synthesis or breakdown of the core lipids ([@bib23]), others are involved in organelle trafficking and interorganellar communication ([@bib22]; [@bib24]; [@bib43]; [@bib67]). Still, other proteins use lipid droplets as depots for storage ([@bib12]).

Enlargement of lipid droplets and proliferation of adipose tissue are central to the obesity epidemic ([@bib18]). On the other side of the spectrum is lipodystrophy, in which adipose tissue fails to develop normally as a result of defects in adipogenesis ([@bib1]). Several transcription factors in the adipogenic pathway have been identified and ordered temporally ([@bib53]).

Compared with our knowledge of the transcriptional control of adipogenesis, we know considerably less about the pathway of lipid droplet assembly. There is general (but not unanimous; [@bib52]) consensus that droplets originate as depositions of neutral lipids between the leaflets of the ER ([@bib41]). Somehow, they grow out toward the cytoplasm as buds and perhaps separate from the ER. However, the details of these steps are not clear. Roles for exchangeable perilipin-ADRP-Tip47 family proteins in droplet budding have been proposed ([@bib63]) with support from recent data ([@bib58]), and phospholipase D1 and extracellular signal--regulated kinase 2 are required in a cell-free droplet budding assay ([@bib2]). Genome-wide screens for aberrant droplet morphologies in knockdown and deletion libraries of flies and yeast have implicated the retrograde pathway, and COPI function in particular, in droplet budding, although it is not clear whether the effect is direct or indirect ([@bib60]; [@bib8]; [@bib25]; [@bib59]). In yeast droplet morphology screens, lipodystrophy proteins have also been implicated in droplet assembly or maintenance, particularly seipin and lipin ([@bib60]; [@bib19]).

The first lipin gene, *Lpin1*, was originally identified by positional cloning from a spontaneously mutated mouse that showed an 80% decrease in adipose tissue mass, transient fatty liver, and peripheral neuropathy ([@bib37]; [@bib51]; [@bib47]). The lipin family in mammals is now known to consist of three genes and five proteins, lipin-1a, -1b, and -1c (alternatively spliced products) and lipin-2 and lipin-3, with different tissue distributions ([@bib47]; [@bib15]). *Saccharomyces cerevisiae* has one homologue originally named *SMP2* ([@bib33]; [@bib47]) and then renamed *PAH1* when lipins were found to encode phosphatidic acid phosphohydrolases that generate DAG ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib27]). Pah1p localization is regulated by phosphorylation; it is dephosphorylated by a microsomal Nem1p--Spo7p phosphatase complex and phosphorylated by Cdc28p (Cdk1) kinase ([@bib55]; [@bib45]). The dephosphorylation by Nem1p results in binding to the membrane bilayer through an amphipathic helix ([@bib35]; [@bib13]). Lipins are largely cytosolic but also colocalize, at least in animal cells, to the nucleus. In that compartment, they regulate adipogenesis and phospholipid biosynthesis through transcriptional modulation; this has been directly demonstrated for lipin-1 ([@bib50]). Thus, the lack of adipose tissue in the lipin-1--deficient mouse is thought to be caused by a combination of transcriptional deficiency and a lack of triglycerides as a result of a low concentration of the DAG precursor.

![***pah1Δ* has fewer lipid droplets but a similar amount of neutral lipid.** (A) Abbreviated diagram showing the final steps in neutral lipid synthesis. Pah1p\*, phosphorylated cytosolic Pah1p; LD, lipid droplet; TAG, triacylglycerol; StE, steryl ester. (B) BODIPY-stained ER rings (arrows). Fluorescence images of cells of the indicated strains containing the ER marker CFP-HDEL, which were cultured in minimal dextrose medium (SD) and stained with BODIPY. Note the fewer droplets in *pah1Δ.* Bar, 5 µm. (C) Comparison of droplet number in wild-type (WT) and *pah1Δ* cells. \*\*\*, P \< 0.0001; droplets in cells (examining z-section series) from four independent experiments, at least 20 cells per field; SEM shown. (D) Total neutral lipid content from mass spectrometry. Means and ranges are shown from two independent experiments.](JCB_201010111_RGB_Fig1){#fig1}

However, DAG itself may play a more direct role in droplet biogenesis. A recent study ([@bib58]) showed that stabilizing DAG in membranes recruited perilipin-3, which associated with newly emerging droplets at the ER.

Here, we report that Pah1p, probably working through DAG, is important for droplet assembly independent of the generation of neutral lipids. In the absence of Pah1p, neutral lipids, particularly StEs, accumulate in the ER. We further show that Nem1p, which targets Pah1p to membranes, is usually adjacent to a droplet, consistent with a role in providing nascent droplets with DAG. Finally, we demonstrate that droplets are not synthesized in cells lacking both Pah1p and the steryl acyltransferases Are1p and Are2p when cultured in glucose medium, although the cells are replete in TAG.

Results
=======

Decrease in droplets but not neutral lipids in *pah1Δ* cells
------------------------------------------------------------

We previously identified 59 yeast gene disruption strains with altered lipid droplet morphology based on staining with the neutral lipid dye BODIPY 493/503 ([@bib60]). In two of these strains, *nem1Δ* and *spo7Δ*, BODIPY-stained rings were apparent in a minor fraction (∼30%) of these cells ([Fig. 1 B](#fig1){ref-type="fig"}). These rings resembled the ER, and indeed, they colocalized with an ER marker, CFP-HDEL (pseudocolored red in the merge images for better visualization; [Fig. 1 B](#fig1){ref-type="fig"}).

The corresponding proteins Nem1p and Spo7p form a complex in the ER ([@bib57]) and recruit yeast lipin, Pah1p ([@bib55]), to convert phosphatidate (PA) to DAG. To determine whether the ring phenotype was related to activation of Pah1p, we generated the deletion strain, *pah1Δ*, which was missing in the library we originally screened. In this strain, BODIPY-staining rings were apparent in every cell and again colocalized with the ER marker. Strikingly, there were only 37% of lipid droplets in this strain compared with wild type ([Fig. 1, B and C](#fig1){ref-type="fig"}). Droplets were more heterogeneous in size in *pah1Δ* than in wild type.

Cell TAG is known to decrease in *pah1Δ* because *PAH1* encodes the main PA phosphatase that normally provides its precursor, DAG ([@bib27]). To determine whether the decrease in lipid droplets in *pah1Δ* can be attributed to an overall decrease in neutral lipids, we measured both TAG and StE in log-phase cells, where the decrease in TAG is not as severe as in stationary phase ([@bib27]). (All fluorescence experiments were also performed in log phase.) As expected, there was a decrease in TAG in *pah1Δ* cells of comparable magnitude to the decrease of lipid droplets, but there was a compensatory increase in StE so that the sum of these two neutral lipid classes, which normally are packaged into droplets, was at least as high in the mutant ([Fig. 1 D](#fig1){ref-type="fig"}). Therefore, the decrease in lipid droplets cannot be attributed to a decrease in overall neutral lipid.

Neutral lipid accumulation in the ER in *pah1Δ*
-----------------------------------------------

The decrease in lipid droplet number without a concomitant decrease in total neutral lipid suggests that there is a defect in droplet biogenesis in *pah1Δ*. If this were the case, neutral lipids should accumulate in the ER or other membranes in this strain. We first considered that the BODIPY-stained ER rings in the strain reflected neutral lipid accumulation. However, the ER proliferates in *pah1Δ* as a consequence of derepression of phospholipid biosynthesis, resulting in nuclear envelope deformation and the appearance of ER stacks ([@bib55]). To determine whether the BODIPY-stained rings in *pah1Δ* might be a result of altered ER morphology rather than neutral lipid accumulation, we stained cells that were disrupted in both *PAH1* and the four acyltransferases that generate TAG and StE ([@bib44]; [@bib48]). BODIPY weakly stained the cytosol in the acyltransferase-deficient "quad" mutant ([Fig. 2 A](#fig2){ref-type="fig"}, 4KO). In contrast, membrane rings were indeed observed when *pah1Δ* was additionally knocked out, generating a "quint" mutant ([Fig. 2 A](#fig2){ref-type="fig"}, 5KO). (The intensities of staining among strains can be directly compared because the absolute intensity range for all images of an experiment was fixed in microscope software.) We conclude that BODIPY 493/503 can stain membrane stacks even devoid of neutral lipids as well as it stains lipid droplets in wild type; thus, it cannot be used to detect membrane neutral lipids in *pah1Δ*.

![**Neutral lipids accumulate in the ER in the absence of *PAH1*.** (A) BODIPY, Nile red, and Oil red O staining of wild type (WT), *pah1Δ*, 4KO (*dga1Δlro1Δare1Δare2Δ*), and 5KO (*pah1Δdga1Δlro1Δare1Δare2Δ*) strains grown in SD medium. Images incorporate both brightfield and fluorescent channel for the indicated lipophilic dyes. Bar, 5 µm. (B) Inclusions in *pah1Δ* membranes seen with transmission electron microscopy. The indicated strains were cultured overnight in oleic acid medium before fixation. *pah1Δ* insets are higher magnifications of boxed areas and are shown to illustrate membrane inclusions. Note the membrane proliferation but no inclusions in the 5KO stain. LD, lipid droplet. (C) Droplet (LD) and membrane (M) levels of TAG and StE in the indicated strains. Postnuclear extracts from spheroplasts (grown in oleate) were fractionated by centrifugation. An identical percentage of the floating droplets and membrane pellets, normalized to total protein in the extracts, was subjected to TLC. Error bars indicate the range of values from two independent experiments.](JCB_201010111_GS_Fig2){#fig2}

However, both Nile red and Oil red O better differentiated neutral lipids from membrane stacks. Nile red intensely stained both membranes and droplets in *pah1Δ*; however, the dye also stained membranes in some cells of the quint mutant, regardless of the emission wavelength used ([Fig. 2 A](#fig2){ref-type="fig"} and not depicted; [@bib64]). In contrast, Oil red O, which is traditionally used to label neutral lipid in plants and animals ([@bib49]), yielded strong patchy staining in *pah1Δ* that was quite different from the punctate appearance of droplets in wild type. In contrast, Oil red O did not stain membranes of the quint mutant at all. Although this result suggested neutral lipid staining in membranes in the *pah1Δ* strain, we could not visualize ER labeled with CFP-HDEL in Oil red O--stained cells to assess colocalization because isopropanol, which destroyed ER morphology, was required for Oil red O staining.

To gain better evidence for ER accumulation of neutral lipids in *pah1Δ*, we cultured the strains in medium with oleic acid to stimulate neutral lipid synthesis and subjected them to electron microscopy. As expected, wild-type cells contained large lipid droplets, which were absent in the quad mutant ([Fig. 2 B](#fig2){ref-type="fig"}). The proliferated ER was clearly seen in *pah1Δ*. Significantly, the membrane stacks contained many electron-transparent inclusions consistent with neutral lipid in this compartment. Sometimes, larger inclusions were seen within the proliferated ER, as if tiny lipid droplets had coalesced ([Fig. S1](http://www.jcb.org/cgi/content/full/jcb.201010111/DC1)). The bilayer structure could not be clearly visualized adjacent to the inclusions, and it was impossible to verify that the inclusions were between leaflets of the bilayer. Nevertheless, these membrane inclusions were entirely absent in the proliferated ER of the quint strain.

To biochemically verify membrane accumulation of neutral lipids in *pah1Δ*, we separated membranes and lipid droplets by ultracentrifugation from postnuclear supernatants of wild-type and *pah1Δ* cells cultured in oleic acid. In wild-type cells, 10.2% of TAG was found in the membrane fraction ([Fig. 2 C](#fig2){ref-type="fig"}). In contrast, 22.0% of TAG was found in membranes in *pah1Δ* cells, although the absolute amount of TAG in membranes was actually decreased 28% in the mutant. Thus, the membrane inclusions in *pah1Δ* were likely not predominantly TAG. In contrast, there was 5.2 times more membrane-associated StE in *pah1Δ* compared with wild type. Based on the large decrease in lipid droplet number with little change in total neutral lipids, membrane staining with Nile red and Oil red O, transparent inclusions seen by electron microscopy, and accumulation of StEs in *pah1Δ* membranes, we conclude that Pah1p is somehow important for assembly of droplets.

It has previously been shown that PA phosphatase activity of Pah1p depends on the intact N-terminal lipin homology domain and haloacid dehalogenase-like domain of the protein ([Fig. 3 A](#fig3){ref-type="fig"}; [@bib27], [@bib28]). To determine whether the low droplet phenotype of *pah1Δ* is caused by the absence of catalytic activity by itself, three point mutants were generated that are known to disrupt activity, and the *pah1Δ* strain was transformed with plasmids encoding intact or mutated Pah1p. Although the wild-type copy of Pah1p was able to revert both the ring ([Fig. 3 B](#fig3){ref-type="fig"}) and droplet phenotype ([Fig. 3 C](#fig3){ref-type="fig"}) to wild type, none of the three point mutants were able to complement the strain. Similarly, only the wild-type allele was able to reverse the accumulation of StE in isolated membrane fractions ([Fig. 2 C](#fig2){ref-type="fig"}). We conclude that the PA phosphatase activity of Pah1p is essential for its effect on droplet biogenesis.

![**PA phosphatase activity of Pah1p is required for efficient formation of lipid droplets.** (A) Diagram of Pah1p primary structure (modified from [@bib28]). NLIP, N-terminal lipin homology domain; HAD, haloacid dehalogenase-like domain. (B) The *pah1Δ* strain expressing the indicated *PAH1* alleles on a pRS313 vector. The ER marker CFP-HDEL was expressed on a plasmid and driven by the *PGK1* promoter. Lipid droplets were stained with BODIPY. Cells were observed in SD medium. Bar, 5 µm. (C) Droplet number per cell in strains shown in B. Error bars represent SEM based on three fields (∼50 cells per field) from three independent experiments. WT, wild type.](JCB_201010111_RGB_Fig3){#fig3}

*PAH1* and StEs in combination are essential for droplet formation
------------------------------------------------------------------

Although total neutral lipid is not decreased in *pah1Δ*, we next asked whether Pah1p was particularly important for packaging TAG versus StE. To address this, we knocked out *PAH1* in cells that either lacked the genes for the two DAG acyltransferases (*DGA1* and *LRO1*) or for the two steryl acyltransferases (*ARE1* and *ARE2*; [@bib66]; [@bib38]). As reported previously ([@bib20]), droplets are formed in the absence of either TAG or StE ([Fig. 4 A](#fig4){ref-type="fig"}), although numbers are reduced, indicating that neither TAG nor StE formation is essential for droplet formation. There was a small (26%) but highly reproducible decrease in droplet number when *PAH1* was disrupted in *dga1Δlro1Δ* cells, even though there was no decrease in total StE in this strain ([Fig. 4, B and C](#fig4){ref-type="fig"}; also see [Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201010111/DC1) and [Tables S2](http://www.jcb.org/cgi/content/full/jcb.201010111/DC1) and [S3](http://www.jcb.org/cgi/content/full/jcb.201010111/DC1) for distribution of acyl chains). If expressed in terms of cell volume (disruption of *PAH1* results in a calculated 96% increase in volume; compare cell sizes in [Fig. 4 A](#fig4){ref-type="fig"}), the decrease in droplet number is 51%. The effect of disrupting *PAH1* in the *are1Δare2Δ* background is much more extreme: no droplets at all were detected in *pah1Δare1Δare2Δ*, even though the cells contained about as much TAG as wild type. In cells cultured in medium containing oleate, the large fatty acid load resulted in some droplet formation in the *pah1Δare1Δare2Δ* strain, but droplets were far fewer in number even compared with *pah1Δ* ([Fig. 4, D and E](#fig4){ref-type="fig"}). Perhaps the presence of droplets in this strain growing in oleic acid medium is caused by reaching saturation for storing neutral lipids in the ER bilayer. We conclude that in the absence of StE, Pah1p is required to form droplets containing TAG in the absence of exogenous fatty acids, although it also facilitates the packaging of StE in the absence of TAG.

![**Knockout of *PAH1* and steryl acyltransferases abolishes lipid droplets in cells grown in glucose medium.** (A) BODIPY staining of the indicated strains in SD. *DGA1* and *LRO1* encode DAG acyltransferases, and *ARE1* and *ARE2* encode steryl acyltransferases. Images incorporate both brightfield and FITC channel (for lipid droplets). Bar, 5 µm. (B) Lipid droplet number in strains shown in A. Droplets in ∼30 cells were counted in z-section series from three independent experiments (∼90 cells total per strain). Mean ± SEM is shown. Knockout of *pah1Δ* always resulted in significantly lower droplets, although the significance in only the middle pair is shown for clarity; \*\*, P \< 0.001. (C) Quantification of TAG and StE from mass spectrometry analysis for the indicated strains grown in SD. Means and ranges from two independent experiments are shown. The values for wild type (WT) and *pah1Δ* are also shown in [Fig. 1 D](#fig1){ref-type="fig"}. (D) BODIPY staining of the indicated strains grown in medium containing oleic acid. Bar, 5 µm. (E) A comparison of droplet number in *pah1Δ* and *pah1Δare1Δare2Δ* grown in oleic acid. Error bars represent standard deviation; \*\*\*, P \< 0.0001; based on two fields (∼50 cells per field) from three independent experiments.](JCB_201010111_RGB_Fig4){#fig4}

Evidence that DAG is important for droplet formation
----------------------------------------------------

Thus far, our data suggest that the DAG generated by Pah1p is important for droplet formation independent of its role as a precursor of TAG. This is consistent with a recent study showing that manipulation of DAG levels in mammalian cells can drastically affect droplet formation ([@bib58]). If DAG is required for the formation of droplets, overproduction of DAG might be able to bypass the role of Pah1p. To test this idea, we forced more DAG formation by eliminating the backward reaction to PA in a DAG kinase knockout strain, *dgk1Δ*. *DGK1* has recently been shown to be important for providing PA for phospholipid synthesis during the lag phase ([@bib17]). We confirmed an increase in DAG and decrease in PA in this strain ([Fig. 5 C](#fig5){ref-type="fig"}), as has been previously reported ([@bib29]; [@bib17]). As predicted, the *dgk1Δ* strain alone had significantly more lipid droplets than wild type ([Fig. 5, A and B](#fig5){ref-type="fig"}), which were often in a "pearls on a string" (defined as four or more lipid droplets in a row spaced ≤0.5 µm apart) on the perinuclear ER ([Fig. 5 A](#fig5){ref-type="fig"}, arrows). The increase in droplets completely bypassed the role of *PAH1* as shown in the *pah1Δdgk1Δ* strain. (In the absence of *PAH1*, DAG can be generated by another Mg^2+^-dependent PA phosphatase activity whose identity has not yet been established \[[@bib27]\].) Even if TAG synthesis was completely blocked, the knockout of *DGK1* resulted in more droplets ([Fig. 5 B](#fig5){ref-type="fig"}, compare droplet number between *dga1Δlro1Δ* and *dgk1Δdga1Δlro1Δ*) and an enhancement of the pearls-on-a-string phenotype ([Fig. 5 D](#fig5){ref-type="fig"}). These data again demonstrate that the production of DAG itself is probably important for droplet formation in yeast.

![**Knockout of DAG kinase leads to more droplets and a bypass in Pah1p function.** (A) Knockout of *DGK1* increases droplet number independent of TAG. The indicated strains were grown in SD, and lipid droplets were stained with BODIPY. Images incorporate brightfield channel. Arrows illustrate pearls-on-a-string phenotype. Bar, 5 µm. (B) Droplet number increases in *dgk1Δ* even in the absence of TAG. The inset illustrates the enzymes that catalyze PA-DAG interconversions; the source for the other PA phosphatase activity is unknown. Droplets were counted in at least three random fields, ∼20 cells per field; mean ± SEM is shown. \*, P \< 0.05; \*\*\*, P \< 0.0001. (C) Comparison of DAG and PA levels of wild type (WT) and *dgk1Δ*, showing an increase in DAG and decrease in PA in the mutant. Error bars are SEM based on measurements from three independent experiments. (D) Histogram showing the percentage of cells with pearls-on-a-string lipid droplet phenotype; mean ± SEM (\*\*, P \< 0.001) based on three random fields (at least 20 cells per field) from three independent experiments.](JCB_201010111_GS_Fig5){#fig5}

The Pah1p phosphatase Nem1p is close to droplets
------------------------------------------------

DAG should be produced at the site of droplet formation for it to be active because otherwise it would rapidly diffuse laterally in the membrane. Pah1p is dephosphorylated on the ER by the membranous Nem1p--Spo7p complex; Nem1p is the catalytic subunit of the activating phosphatase ([@bib55]), which results in membrane localization of Pah1p, where it is active ([@bib35]; [@bib13]). Both Spo7p-GFP and GFP-Nem1p localize to the ER when exogenously expressed ([@bib57]), whereas GFP knocked in behind the *NEM1* reading frame revealed puncta of uncertain origin ([@bib32]). To more closely examine the localization of Nem1p, we tagged the chromosomal copy of *NEM1*, keeping the endogenous promoter intact, with mCherry. We confirmed that Nem1p forms puncta, and they colocalized with the ER marker CFP-HDEL ([Fig. 6 A](#fig6){ref-type="fig"}, bottom left inset). (As expected, GFP-tagged Spo7p colocalized in puncta with dtTomato-tagged Nem1p \[[Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201010111/DC1)\].) Interestingly, only one Nem1p-mCherry punctum was usually found per cell (viewing through z sections); only 3% of cells had two puncta, and none had more. Most of the puncta were in close proximity to BODIPY-stained droplets ([Fig. 6 A](#fig6){ref-type="fig"}). By scoring the proximity of Nem1p-mCherry to droplets in three dimensions, 77% of them appeared to be in contact with droplets, whereas only 13% could clearly be resolved from droplets ([Fig. 6 B](#fig6){ref-type="fig"}). The proximity to droplets was clearly visualized in a computer-aided projection of a field of cells ([Fig. 6 A](#fig6){ref-type="fig"}, right; and [Video 1](http://www.jcb.org/cgi/content/full/jcb.201010111/DC1)). 10 out of 12 Nem1p-mCherry puncta within the field were within 0.65 µm of a droplet, the limit of resolution in this method.

![**Nem1p localizes next to lipid droplets on the ER.** (A) Nem1p-mCherry was chromosomally expressed at the *NEM1* locus. Lipid droplets were stained with BODIPY. (top left) Brightfield image. (bottom left) Projection image of BODIPY-stained cells showing Nem1p-mCherry localization (bottom left inset). The arrowhead is an example of colocalization of CFP-HDEL (ER), BODIPY (lipid droplet), and Nem1p-mCherry. Bars, 5 µm. (right) Three-dimensional reconstruction of the same field of cells. Green, droplets; pink (10 dots), Nem1p within 0.65 µm of a droplet; blue (two dots with arrowheads), Nem1p-mCherry beyond 0.65 µm of a droplet. (B) Juxtaposition of Nem1p-mCherry puncta with lipid droplets (LD). Nem1p-mCherry puncta were counted from seven separate groups of cells and scored for their observed association with lipid droplets. Mean ± SEM was calculated across all seven groups.](JCB_201010111_RGB_Fig6){#fig6}

To observe the colocalization of Nem1p with droplets in another way, we subjected membranes derived from a postnuclear supernatant of cells expressing Nem1p-mCherry in the genome to fluorescence microscopy. When grown on glucose medium, droplets were small, and some remained attached to the ER even after centrifugation; these can be visualized as puncta with BODIPY in this preparation ([Fig. 7](#fig7){ref-type="fig"}). Most of these spots also coincided with mCherry staining. In contrast, when membranes containing the CFP-HDEL marker were analyzed, there was no colocalization with lipid droplets. The proximity of Nem1p to droplets suggests that Pah1p docks onto the Nem1p--Spo7p complex, where it provides DAG (and later TAG) during droplet production. In yeast, we have observed rapid lateral movement of droplets on the surface of the ER, but never dissociation ([Video 2](http://www.jcb.org/cgi/content/full/jcb.201010111/DC1)). Perhaps the ∼20% of Nem1p puncta that are clearly separated from droplets are cycling to a new droplet after one is fully formed. In summary, our data strongly suggest that DAG is produced by Pah1p at the site of droplet formation, where it plays an important role in biogenesis of cytoplasmic lipid droplets.

![**Colocalization of Nem1p-mCherry and droplets in isolated membranes.** Membranes derived from postnuclear supernatant of yeast strains containing chromosomally expressed Nem1p-mCherry (left) or plasmid-expressed 3-phosphoglycerate kinase (PGK) CFP-HDEL (right) were stained with BODIPY. The arrowheads point to three examples of colocalization of Nem1p-mCherry and BODIPY puncta on membranes. Bar, 5 µm.](JCB_201010111_RGB_Fig7){#fig7}

Discussion
==========

The fatty liver dystrophy mouse, the result of a spontaneous mutation in lipin-1, displays a serious defect in adipogenesis ([@bib47]). The defect is consistent with the known roles that lipin-1 plays as a PA phosphatase and a transcriptional regulator of lipid metabolism, both of which lead to low cellular TAG levels ([@bib50]). In this study, we add another likely function for at least the yeast lipin homologue, as a facilitator in lipid droplet assembly through its generation of DAG, independent of TAG formation.

We have presented several lines of evidence that support this novel activity of Pah1p. (a) The absence of *PAH1* results in low droplet number, whereas total neutral lipids are not decreased. This results in accumulation of neutral lipids in membranes. (b) PA phosphatase catalytic activity is required for this function. (c) There is a decrease in droplet assembly in *pah1Δ* regardless of whether cells can synthesize only TAG or StE, although the effect is most profound in the absence of StE. (d) The importance of DAG in droplet formation is suggested by the increase in droplets if DAG concentration is not regulated in *dgk1Δ* cells, even if no TAG is synthesized. (e) The activator of Pah1p, the protein phosphatase Nem1p, is localized next to droplets 80--85% of the time.

The neutral lipid identity of the electron-transparent inclusions observed for *pah1Δ* is supported by an increase in membrane StEs ([Fig. 2 C](#fig2){ref-type="fig"}). The biochemical analysis of the membrane fraction may underestimate the membrane neutral lipids in the strain. Because droplets remain attached to the ER, it requires high centrifugal force (∼200,000 *g*) to separate most neutral lipids from the membranes of wild-type cells (unpublished data). This high force may also remove neutral lipids stored in the membrane of the *pah1Δ* mutant.

We report that both tagged Nem1p and Spo7p yield a punctate appearance in cells, in contradiction to a previous finding ([@bib57]) in which the ER and other membranes were stained. Expression levels and background strains may contribute to this difference because [@bib57] could not detect Nem1p driven by its endogenous promoter. Although that group detected ER-stained Spo7p expressed from its own promoter, they used a different background strain.

The demonstration of one punctum of Nem1p-mCherry per cell that is next to droplets was unexpected. The localization of its mammalian homologue (Dullard) is punctate, but in multiple regions around and inside the nucleus ([@bib36]). The unique localization of Nem1p in yeast may provide an opportunity for understanding the biogenesis of lipid droplets. Its single punctum is in contrast to seipin, another lipodystrophy protein, which is found on the ER next to most, if not all, droplets ([@bib60]; [@bib19]). Whether seipin and Spo7p--Nem1p physically interact is unknown; we have failed thus far to detect binding (unpublished data). The single Nem1p punctum may mark a developing lipid droplet, whereas seipin may be required by all droplets and serve a maintenance role. Our ability to visualize the Nem1p puncta by normal epifluorescence microscopy indicates that several copies of the protein must localize there, possibly resulting in several associated Pah1p molecules and a high local concentration of DAG. The 15--20% of the Nem1p-mCherry puncta that is well resolved from lipid droplets may indicate inactive protein, association with nascent droplets not yet visualized with BODIPY, or possibly lateral movement of droplets away from the Nem1p puncta; such rapid movement of droplets can be observed in Video 2. When DAG concentration is uncontrolled in *dgk1Δ*, spontaneous droplet formation may occur, leading to the pearls-on-a-string droplet phenotype ([Fig. 5](#fig5){ref-type="fig"}).

Although it is attractive to consider Nem1p (in combination with Spo7p) as a dock for Pah1p, it is unknown whether the latter actually remains attached once binding initially occurs. Recent experiments show that dephosphorylation of Pah1p results in exposure of an N-terminal amphipathic helix, which can bind to membranes independent of Nem1p ([@bib35]). If Pah1p diffused away from Nem1p after activation, it is hard to imagine that DAG would be as effective in droplet formation, assuming that the Nem1p punctum concentrates Pah1p at that site. However, under conditions that favor Nem1p-independent binding of Pah1p to membranes, it still colocalizes with tagged Spo7p, suggesting a more permanent complex ([@bib35]).

The single Nem1p punctum per cell also provides an avenue for studying the dynamics of lipid droplet formation. For example, if Nem1p-mCherry marks only nascent droplets, it should colocalize with the first droplet produced in a system in which droplet formation can be regulated. This hypothesis also predicts that multiple droplets do not develop simultaneously in yeast.

The inability of cells to form lipid droplets in the absence of StE and Pah1p-derived DAG in glucose-grown cells was surprising. One explanation might be that there is an accumulation of unesterified sterol that stiffens the membrane ([@bib5]), preventing droplet formation. This appears unlikely because droplets form in the *are1Δare2Δ* mutant, although in this case, DAG from Pah1p may overcome this effect. Another possibility is that there is a threshold of total cell neutral lipids before a droplet can form and that the sum of TAG and StE in *are1Δare2Δpah1Δ*, which was about half of that in the other strains in this experiment, is below that threshold.

We favor a third explanation, shown in the simple working model of [Fig. 8](#fig8){ref-type="fig"}. There are two pathways to droplet formation in this model, one requiring DAG from Pah1p (unless it is overproduced in *dgk1Δ*) and the other requiring Are1p and/or Are2p. Some droplets will form if either Pah1p or Are1/2p is active, but none will form in the absence of both unless exogenous fatty acids are provided. For the first arm, our data indicate that DAG rather than TAG facilitates droplet formation, as discussed in Results. The effect of DAG in perturbing phospholipid bilayers, promoting high curvature of leaflets, and conversion to hexagonal phase structures is well known ([@bib21]). DAG clearly promotes budding and fission of vesicles from membranes, such as the Golgi complex ([@bib54]; [@bib4]). Although DAG can bend a membrane even more than PA because of its smaller head group, it is unstable in a bilayer and can rapidly flip-flop ([@bib46]), leading to membrane instability that may promote bud formation. Our knowledge of the roles of DAG in diverse membrane-localized cell physiology continues to expand rapidly ([@bib11]). It is possible that the role of DAG is indirect, for example, in recruiting other molecules important for trafficking, such as ARF GTPase-activating protein ([@bib3]) or, in mammalian cells, perilipin-3 ([@bib58]). In our in vivo approach, we also cannot rule out potential effects of other lipids, the concentration of which are altered in the *pah1Δ* strain.

![**Working model.** Droplets are controlled by Pah1p-generated DAG and Are1p/Are2p-generated StEs in normal glucose medium. The dotted line indicates the possibility that these two inputs control two populations of droplets. St, sterol.](JCB_201010111_RGB_Fig8){#fig8}

Regarding the second arm of the model, how can Are1/2p promote droplet formation? Perhaps the combination of a local decrease in sterol as a result of the action of Are1/2p and an accumulation of StE between the monolayers of the membrane, forcing them apart, is sufficient to nucleate a droplet.

Our model shows the input of DAG and Are1/2p in the formation of a single droplet. A local high concentration of both DAG and StE may function synergistically in droplet assembly. The dashed line that bisects the droplet in [Fig. 8](#fig8){ref-type="fig"} is meant to indicate the possibility that these two inputs control the assembly of different droplets, one predominantly composed of TAG and the other composed of StE. Although there is evidence for a droplet containing both TAG and StE ([@bib14]), there also is ample evidence for droplet heterogeneity ([@bib16]; [@bib31]).

The current model for droplet formation envisions a lens of neutral lipid developing between the ER leaflets that enlarges to produce a droplet bud that evaginates from the plane of the ER ([@bib41]; [@bib63]). A direct role of DAG, produced by Pah1p at the ER membrane, in promoting the formation of droplets is consistent with this model. Now that several other factors for droplet assembly have been implicated through genetic screens, proteomics, and other approaches, future efforts will focus on how these factors coordinate droplet assembly.

Materials and methods
=====================

Reagents
--------

Restriction enzymes, DNA ligases, and other reagents for DNA manipulation were purchased from New England Biolabs, Inc., Roche, and Bio-Rad Laboratories. Neutral lipid standards were obtained from Nu-Chek Prep, Inc. Zymolyase 100T was purchased from US Biologicals, and hygromycin was bought from A.G. Scientific. All other chemical reagents were obtained from Sigma-Aldrich or Thermo Fisher Scientific.

Yeast strains and growth conditions
-----------------------------------

All yeast strains and plasmids used in this study are listed in [Table S1](http://www.jcb.org/cgi/content/full/jcb.201010111/DC1). Strains SCY1703, SCY1998, and SCY328 were gifts from S. Sturley (Columbia University, New York, NY). To generate strain BY4742-KS001, we used the cassette within pGH317 provided by G.S. Han and G. Carman (Rutgers University, New Brunswick, NJ), and we followed their procedure to generate a *PAH1* knockout from the cassette ([@bib27]) in BY4742. In brief, the cassette consisted of the URA3 gene flanked by ∼400 bp of upstream and downstream *PAH1* sequence.

Cells were cultured at 30°C in 2% glucose or in oleic acid ([Fig. 2, B and C](#fig2){ref-type="fig"}; and [Fig. 4, D and E](#fig4){ref-type="fig"}) as previously described ([@bib30]). All cultures were harvested during log-phase growth.

DNA manipulations
-----------------

All plasmids used in this study are listed in Table S1. Standard recombinant DNA techniques were used. Bacterial strain DH10β (Invitrogen) was used for all bacterial transformations. Site-directed mutations to plasmids were performed using the QuikChange site-directed mutagenesis kit (Agilent Technologies). *PAH1* knockout in OAS001, OAS002, and OAS003 strains was performed by homologous recombination using a DNA cassette containing ∼500 bp of *PAH1* sequence (from the 5′ and 3′ untranslated region flanking the *PAH1* ORF) ligated to opposite ends of a *TRP1* sequence. The BY4742-SL001 strain was generated by homologous recombination with the use of a DNA cassette containing mCherry followed by the *PGK1* 3′ terminator and *URA3* to the 3′ end of the *NEM1* ORF. BY4741-Spo7p-GFP-Nem1p-tdTomato was generated similarly from BY4741-Spo7p-GFP except that the cassette contained tdTomato instead of mCherry and the hygromycin-resistance marker (a gift from B. Tu, University of Texas Southwestern, Dallas, TX) instead of *URA3*; selection of transformants was performed on rich plates containing 300 µg/ml hygromycin. Yeast strains were transformed by the lithium acetate method ([@bib34]). DNA manipulations resulting in changes to coding sequence as well as changes to genome were verified by sequence performed by the McDermott Center for Human Growth and Development.

Fluorescence and electron microscopy
------------------------------------

All microscopy was performed at room temperature. For the acquisition of static images, strains were stained with BODIPY 493/503 (Invitrogen; [@bib60]) to visualize lipid droplets and transformed ([Figs. 1 B](#fig1){ref-type="fig"}, [3 B](#fig3){ref-type="fig"}, and [7](#fig7){ref-type="fig"}) with pRS315-PGK-CFP-HDEL to visualize the ER. Cells in log phase were removed from growth medium, concentrated by centrifugation (3,000 *g* for 5 min at room temperature), and suspended on microscope slides in growth medium containing 1% agar ([@bib39]). All images were acquired in Slidebook (version 4.1.0.3; Intelligent Imaging Innovations) using a microscope (Axiovert 200M; Carl Zeiss, Inc.) with a 100× 1.3 NA oil immersion objective lens (plan-Neofluar) equipped with a digital camera (Sensican; Cooke). BODIPY images were acquired using the fluorescein isothiocyanate filter set, CFP with the CFP filter set, and mCherry with the CY3 filter set (Chroma Technology Corp.). Z stacks were obtained at 0.3-µm spacing, and Slidebook commands of deconvolution (nearest neighbor option) were used to build images through cells. For [Fig. 2 A](#fig2){ref-type="fig"} and [Fig. 4 (A and D)](#fig4){ref-type="fig"}, the range of pixel intensities used for the control strain to clearly visualize droplets was fixed and used for the other strains in the series so the images could be directly compared.

To observe movement of lipid droplets on the ER membrane, BY4742-DB001 expressing the ER marker GFP-HDEL was grown in glucose to log phase and subjected to spinning disk confocal microscopy using a spinning disk confocal system (Ultraview ERS; PerkinElmer) set up on a microscope (Axiovert 200M) with a camera (Orca; Hamamatsu Photonics) in the University of Texas Southwestern Live Imaging Core. Lipid droplets and ER were followed for 4.5 min by saving images over 32 planes (0.2 µm between planes), cycling every 5 s. To generate the QuickTime videos, data were collected over five continuous planes (0.2 µm between them) every 4--5 s and projected into one image per time point.

To visualize Nile red--stained cells, samples were processed and observed as previously published ([@bib64]). In brief, cells were fixed in 2% vol/vol formaldehyde, incubated for 1 min at room temperature, and washed twice in 50 mM Tris buffer, pH 7.5, before observation. Oil red O--stained cells were processed and observed as previously described ([@bib9]). In brief, cells were washed with H~2~O and resuspended in freshly filtered Oil red O solution (three parts of 1% stock in isopropanol and two parts H~2~O). After 10 min of stain, cells were washed twice and observed. Three-dimensional reconstruction ([Fig. 6 A](#fig6){ref-type="fig"}, right) was performed using Imaris software (Bitplane AG).

For electron microscopy, yeast cells were grown in 0.1% oleate medium and processed in the University of Texas Southwestern Molecular and Cellular Imaging Facility as previously described ([@bib65]; [@bib9]). In brief, cells were fixed in potassium permangenate, dehydrated, and postfixed in uranylacetate before sectioning.

Lipid analysis
--------------

Lipid extraction and one-dimensional TLC analysis were performed as previously described ([@bib9]) with few modifications. Yeast cell pellets were treated with Zymolyase 100T at 4 mg/1,000 OD~600~ for 40 min at 30°C. Spheroplasts were weighed and subjected to hot isopropanol and chloroform extraction. Thin layer plates were charred with 3% cupric acetate and 8% phosphoric acid solution, and lipid bands were digitally scanned and analyzed using ImageJ (v.1.41; National Institutes of Health).

Samples subjected to mass spectrometric analysis were spiked with an internal standard mixture composed of 2 µg tri-TAG (15:0), 4 µg tri-TAG (21:0), 2 µg cholesteryl ester (13:0), and 4 µg cholesteryl ester (19:0). Samples were suspended in 0.4 ml chloroform and fractionated by silica gel column chromatography (6 ml Supelco Discovery DSC-Si and 500 mg of solid-phase extraction cartridges). Columns were preconditioned with hexane, and lipids were separated by sequential elution with solvents (hexane/diethyl ether \[4:1, vol/vol\], hexane/diethyl ether \[1:1, vol/vol\], methanol, and finally chloroform; [@bib40]). Solvents were evaporated off with N~2~ before suspending neutral lipid in 0.1 ml chloroform. Neutral lipid fractions were diluted into chloroform-methanol \[1:1, vol/vol\] plus 10 mM aqueous ammonium acetate. Samples were introduced by direct infusion at a flow rate of 750 µl/h into the electrospray source of liquid chromatography tandem mass spectrometry (Waters Micromass Quattro Ultima Triple Quadrupole). TAGs and StEs were quantified in full-scan mode. Neutral loss scans for TAGs and StE were used separately to verify acyl chain compositions and head group. The collision energies, with argon in the collision cell, were 20 V for TAGs and StE. Full and neutral loss/precursor scans were acquired in continuum mode and averaged over 60 and 30 s, respectively. Conditions for acquisition were all under a positive capillary voltage of 3.50 kV, cone gas of 80 ml/h, desolvation gas of 200 ml/h, 80°C source temperature, and 200°C desolvation temperature. The background of each spectrum was subtracted using a solvent blank, the peak areas integrated, isotopic overlap and response correction factors applied, and peaks quantified against their respective internal standards using in-house Visual Basic macros developed in Microsoft Excel.

Cell lysis and organelle fractionation
--------------------------------------

Yeast microsomes were prepared as described previously ([@bib10]) with few modifications. The postnuclear supernatant in yeast lysis buffer (20 mM Hepes, pH 7.4, 200 mM sorbitol, 50 mM KOAc, 2 mM EDTA, and protease inhibitor cocktail: 0.2 mM 4-\[2-aminoethyl\]benzenesulfonyl fluoride hydrochloride, 1.2 µg/ml pepstatin A, 1.2 µg/ml leupeptin, 12 µg/ml *p*-toluenesulfonyl-[l]{.smallcaps}-arginine methyl ester, 12 µg/ml tosyl-lysyl-chloromethylketone, 12 µg/ml *p*-nitroenzoyl-[l]{.smallcaps}-arginine methyl ester, and 12 µg/ml soybean trypsin inhibitor) was loaded into a tube (SW60; Beckman Coulter), layered with a 1-ml Hepes cushion (20 mM Hepes, pH 7.4, 100 mM KCl, and 2 mM MgCl~2~), and centrifuged at 38,000 rpm for 1 h at 4°C in a rotor (SW60). Floating lipid droplet and membrane pellets were collected and taken through the lipid analysis procedure as described in the previous section. For [Fig. 7](#fig7){ref-type="fig"}, membrane pellets of the required yeast strain were resuspended gently in 0.5 ml lysis buffer and stained for 10 min with BODIPY 493/503 before observation by fluorescence microscopy.

Online supplemental material
----------------------------

The online supplemental material contains a table of strains and plasmids used in this study (Table S1), mass spectroscopic analysis of TAG chain length and StE sterol subtypes in various strains (Tables S2 and S3 and Fig. S2), electron micrographs showing neutral lipid inclusions in *pah1Δ* (Fig. S1), localization of tagged Pah1p and colocalization of tagged Nem1p and Spo7p (Fig. S3), animation of the proximity of Nem1p with lipid droplets (Video 1), and movement of droplets on ER membranes (Video 2). Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201010111/DC1>.
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